NASDAQ$BRKR
Bruker Corp · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Bruker's Q1 2020 financial performance was impacted by COVID-19, resulting in revenue decline.
Bruker reported a revenue decline of 8.1% year-over-year, with an organic revenue decline of 7.9%. GAAP EPS decreased to $0.07 from $0.20 in Q1 2019, and non-GAAP EPS decreased to $0.14 from $0.28 in Q1 2019. The company expects COVID-19 disruptions to negatively affect Q2 2020 financial results.
- Q1 2020 revenue declined by 8.1% year-over-year.
- Organic revenue declined by 7.9%.
- GAAP EPS was $0.07, compared to $0.20 in Q1 2019.
- Non-GAAP EPS was $0.14, compared to $0.28 in Q1 2019.
Headline financials
Revenue & EPS history
Bruker · Revenue · Quarterly
$424M
Revenue by segment
Bruker · $70.6M total across 1 segment · Q3 2023
- BEST$70.6M+19.1%100.0%
Forward guidance
Bruker anticipates that the pandemic will have a more significant negative impact on the Company’s second quarter 2020 financial results. Fiscal Year 2020 (FY 2020) Guidance Remains Suspended
Tailwinds
- Bruker is a healthy, essential company.
- Life science tools and diagnostics markets are quite resilient.
- Long-term funding trends in life science, biopharma and basic medical research, as well as in infectious disease diagnostics, are going to be strong as a result of the COVID-19 pandemic.
- Bruker is well positioned for a gradually improving business environment in the second half of 2020.
- Bruker continues to have a strong balance sheet and a very solid liquidity position.
Headwinds
- COVID-19 disruption expected to negatively affect Q2 2020 financial results.
- First quarter 2020 results reflect the initial impact of the COVID-19 pandemic.
- Expect a more pronounced year-over-year revenue decline in the second quarter.
- Fiscal Year 2020 (FY 2020) Guidance Remains Suspended
- Uncertain business conditions created by COVID-19.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
+0.8%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+3.3%
Avg return
30 days after
54%
35 / 65 earnings
Positive
+14.1%
Q1 2019
Best reaction
-13.1%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +11.2% | +13.8% | +48.3% | |
| Q4 2025 | -11.6% | -10.2% | -20.5% | |
| Q3 2025 | +6.4% | +2.5% | +22.9% | |
| Q1 2025 | +3.4% | +2.1% | -2.9% | |
| Q4 2024 | -1.0% | -1.7% | -11.0% | |
| Q3 2024 | -0.6% | -2.7% | -1.5% | |
| Q2 2024 | -5.1% | -2.4% | +2.8% | |
| Q1 2024 | -11.4% | -5.9% | -17.1% | |
| Q4 2023 | +13.4% | +15.9% | +30.1% | |
| Q3 2023 | +3.2% | +2.2% | +15.9% | |
| Q2 2023 | -6.7% | -7.6% | -7.1% | |
| Q1 2023 | -2.1% | -4.9% | -11.0% | |
| Q4 2022 | +5.2% | +7.3% | +1.0% | |
| Q3 2022 | +9.5% | +8.7% | +9.6% | |
| Q2 2022 | -7.4% | -9.3% | -18.2% | |
| Q1 2022 | +1.2% | -4.0% | +5.3% | |
| Q4 2021 | -7.7% | -3.9% | -12.1% | |
| Q3 2021 | +1.7% | +1.7% | +0.9% | |
| Q2 2021 | -1.8% | +0.4% | +8.7% | |
| Q1 2021 | -0.5% | -0.0% | +1.4% | |
| Q4 2020 | +1.1% | +3.5% | -1.1% | |
| Q3 2020 | +3.4% | +9.2% | +21.6% | |
| Q2 2020 | +0.2% | -1.1% | -4.1% | |
| Q1 2020 | +6.2% | +4.3% | +16.9% | |
| Q4 2019 | -4.0% | -21.4% | -8.1% | |
| Q3 2019 | +12.4% | +6.8% | +14.9% | |
| Q2 2019 | -13.1% | -12.7% | -9.8% | |
| Q1 2019 | +14.1% | +11.3% | +9.6% | |
| Q4 2018 | +6.3% | +7.4% | +8.5% | |
| Q3 2018 | +6.6% | +6.9% | +5.8% | |
| Q2 2018 | +7.4% | +7.0% | +9.1% | |
| Q1 2018 | +2.0% | +2.9% | +3.4% | |
| Q4 2017 | -7.8% | -5.9% | -6.8% | |
| Q3 2017 | +4.5% | +2.8% | +9.2% | |
| Q2 2017 | -1.2% | -3.1% | +3.2% | |
| Q1 2017 | +3.8% | +4.7% | +12.1% | |
| Q4 2016 | -1.8% | -1.2% | -3.1% | |
| Q3 2016 | +3.6% | +8.9% | +10.1% | |
| Q2 2016 | -12.2% | -10.6% | -9.6% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | +9.5% | — | — | |
| Q3 2015 | +7.8% | — | — | |
| Q2 2015 | -5.4% | — | — | |
| Q1 2015 | +10.6% | — | — | |
| Q4 2014 | -2.1% | — | — | |
| Q3 2014 | -12.5% | — | — | |
| Q2 2014 | -9.4% | — | — | |
| Q1 2014 | -0.8% | — | — | |
| Q4 2013 | +2.0% | — | — | |
| Q3 2013 | -7.1% | — | — | |
| Q2 2013 | +11.1% | — | — | |
| Q1 2013 | -4.3% | — | — | |
| Q4 2012 | +8.3% | — | — | |
| Q3 2012 | +4.1% | — | — | |
| Q2 2012 | -1.6% | — | — | |
| Q1 2012 | +7.4% | — | — | |
| Q4 2011 | -0.9% | — | — | |
| Q4 2009 | -0.9% | — | — | |
| Q3 2010 | -4.0% | — | — | |
| Q3 2011 | -4.0% | — | — | |
| Q2 2010 | +4.0% | — | — | |
| Q2 2011 | +4.0% | — | — | |
| Q1 2010 | +1.9% | — | — | |
| Q4 2010 | +1.9% | — | — | |
| Q1 2011 | +1.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro